GlassScriptPhysician profile
Kristi Duffield
NPI 1871700815
$4,252.98
in general payments reported to CMS, 2019-2025
27 companies · $1,343 in 2025
The $1,343 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $932 · 2022: $489 · 2023: $542 · 2024: $947 · 2025: $1,343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,832.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,214.33 | 2022-2025 | |
| Lundbeck LLC | $525.48 | 2022-2025 | Vyepti |
| Abbott Laboratories | $472.38 | 2021-2025 | Proclaim, Octrode |
| Pfizer INC. | $380.40 | 2021-2025 | |
| Lilly USA, LLC | $364.39 | 2021-2024 | Emgality, Reyvow |
| Amgen INC. | $242.57 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $222.35 | 2021-2025 | Ztlido |
| Vertex Pharmaceuticals Incorporated | $208.94 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $70.52 | 2021 | |
| Protega Pharmaceutials INC | $63.22 | 2025 | Roxybond |
| Collegium Pharmaceutical, INC. | $55.55 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.08 | 2021 | |
| Biodelivery Sciences International, INC. | $51.44 | 2021 | |
| Almatica Pharma LLC | $37.00 | 2021 | |
| Amneal Pharmaceuticals LLC | $28.89 | 2023 | Lyvispah |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $28.44 | 2025 | Symbravo |
| Spr Therapeutics, INC | $27.92 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.27 | 2022 | |
| Nalu Medical, INC. | $24.39 | 2023 | Nalu Neurostimulation System |
| Curonix LLC | $22.86 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kowa Pharmaceuticals America, INC. | $21.51 | 2023 | Seglentis |
| Nevro Corp. | $20.69 | 2024 | Senza |
| Azurity Pharmaceuticals, INC. | $18.78 | 2023 | Horizant |
| Virtus Pharmaceuticals LLC | $18.42 | 2021 | |
| Supernus Pharmaceuticals, INC. | $18.31 | 2021 | |
| Organogenesis INC. | $17.08 | 2021 | |
| Currax Pharmaceuticals LLC | $15.77 | 2024 | Onzetra Xsail |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristi Duffield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.